Top

Published in:

01-02-2018 | Original Article

Preoperative chronic kidney disease is predictive of oncological outcome of radical cystectomy for bladder cancer

Authors: Akihiko Matsumoto, Tohru Nakagawa, Atsushi Kanatani, Masaomi Ikeda, Taketo Kawai, Jimpei Miyakawa, Satoru Taguchi, Akihiro Naito, Masafumi Otsuka, Yasukazu Nakanishi, Motofumi Suzuki, Fumitaka Koga, Yasushi Nagase, Yasushi Kondo, Toshikazu Okaneya, Yoshinori Tanaka, Hideyo Miyazaki, Tetsuya Fujimura, Hiroshi Fukuhara, Haruki Kume, Yasuhiko Igawa, Yukio Homma

Published in: World Journal of Urology | Issue 2/2018

Abstract

Purpose

To evaluate the impact of preoperative chronic kidney disease (CKD) on oncological outcomes after radical cystectomy (RC) for bladder cancer.

Methods

We reviewed the medical records of patients with urothelial bladder carcinoma who underwent RC with curative intent at seven hospitals between 1990 and 2013. After excluding patients with a history of upper urinary tract urothelial cancer or neoadjuvant chemotherapy, we analyzed 594 cases for the study. Preoperative estimated glomerular filtration rate (eGFR) was calculated using the three-variable Japanese equation for GFR estimation from serum creatinine level and age. Patients were divided into four groups of different CKD stages based on eGFR values (mL/min/1.73 m²), i.e., ≥ 60 (CKD stages G1–2), 45–60 (G3a), 30–45 (G3b), and < 30 (G4–5). Survival was estimated using the Kaplan–Meier method. Univariate and multivariate Cox proportional hazards regression analyses addressed survivals after RC.

Results

Median age of patients was 67 years. Patients were classified into CKD stages: G1–2 (n = 388; 65.3%), G3a (n = 122; 20.5%), G3b (n = 51; 8.6%), and G4–5 (n = 33; 5.6%). During a median follow-up of 4.0 years, 200 and 164 patients showed cancer progression and died of bladder cancer, with the 5-year progression-free survival (PFS) and cancer-specific survival (CSS) of 64.9 and 70.2%, respectively. On multivariate analyses, CKD stages of G3b or greater, advanced pT stage, lymph node metastasis, and positive lymphovascular invasion were independent poor prognostic factors for PFS and CSS.

Conclusions

We demonstrated that the advanced preoperative CKD stage was significantly associated with poor oncological outcomes of the bladder cancer after RC.

Available only for authorised users

Antoni S, Ferlay J, Soerjomataram I, Znaor A, Jemal A, Bray F (2017) Bladder cancer incidence and mortality: a global overview and recent trends. Eur Urol 71:96–108CrossRefPubMed

Stamatakis L, Godoy G, Lerner SP (2012) Innovations in radical cystectomy and pelvic lymph node dissection. Semin Oncol 39:573–582CrossRefPubMed

Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, McAlister F, Garg AX (2006) Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol 17:2034–2047CrossRefPubMed

Weng PH, Hung KY, Huang HL, Chen JH, Sung PK, Huang KC (2011) Cancer-specific mortality in chronic kidney disease: longitudinal follow-up of a large cohort. Clin J Am Soc Nephrol 6:1121–1128CrossRefPubMedPubMedCentral

Iff S, Craig JC, Turner R, Chapman JR, Wang JJ, Mitchell P, Wong G (2014) Reduced estimated GFR and cancer mortality. Am J Kidney Dis 63:23–30CrossRefPubMed

Fossa SD, Waehre H, Aass N, Jacobsen AB, Olsen DR, Ous S (1993) Bladder cancer definitive radiation therapy of muscle-invasive bladder cancer. A retrospective analysis of 317 patients. Cancer 72:3036–3043CrossRefPubMed

Thrasher JB, Frazier HA, Robertson JE, Dodge RK, Paulson DF (1994) Clinical variables which serve as predictors of cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate. Cancer 73:1708–1715CrossRefPubMed

Yang MH, Yen CC, Chen PM, Wang WS, Chang YH, Huang WJ, Fan FS, Chiou TJ, Liu JH, Chen KK (2002) Prognostic-factors-based risk-stratification model for invasive urothelial carcinoma of the urinary bladder in Taiwan. Urology 59:232–238CrossRefPubMed

Fokdal L, Hoyer M, von der Maase H (2004) Treatment outcome and prognostic variables for local control and survival in patients receiving radical radiotherapy for urinary bladder cancer. Acta Oncol 43:749–757CrossRefPubMed

10.

Rausch S, Hennenlotter J, Todenhöfer T, Aufderklamm S, Schwentner C, Sievert KD, Stenzl A, Gakis G (2014) Impaired estimated glomerular filtration rate is a significant predictor for non-muscle-invasive bladder cancer recurrence and progression—introducing a novel prognostic model for bladder cancer recurrence. Urol Oncol 32:1178–1183CrossRefPubMed

11.

Li CE, Chien CS, Chuang YC, Chang YI, Tang HP, Kang CH (2016) Chronic kidney disease as an important risk factor for tumor recurrences, progression and overall survival in primary non-muscle-invasive bladder cancer. Int Urol Nephrol 48:993–999CrossRefPubMed

12.

Kwon T, Jeong IG, Lee C, You D, Hong B, Hong JH, Ahn H, Kim CS (2016) Acute kidney injury after radical cystectomy for bladder cancer is associated with chronic kidney disease and mortality. Ann Surg Oncol 23:686–693CrossRefPubMed

13.

Mostofi FK, Sobin LH, Torloni H (1973) Histological typing of urinary bladder tumours. In: International classification of tumours. World Health Organization, Geneva, p 21–31

14.

Sobin LH, Gospodarowicz MK, Wittekind C (2009) TNM classification of malignant tumours, 7th edn. Wiley-Blackwell, Oxford

15.

Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A (2009) Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53:982–992CrossRefPubMed

16.

Imai E, Horio M, Nitta K, Yamagata K, Iseki K, Hara S, Ura N, Kiyohara Y, Hirakata H, Watanabe T, Moriyama T, Ando Y, Inaguma D, Narita I, Iso H, Wakai K, Yasuda Y, Tsukamoto Y, Ito S, Makino H, Hishida A, Matsuo S (2007) Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease. Clin Exp Nephrol 11:41–50CrossRefPubMed

17.

Kanda Y (2013) Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant 48:452–458CrossRefPubMed

18.

Wong G, Staplin N, Emberson J, Baigent C, Turner R, Chalmers J, Zoungas S, Pollock C, Cooper B, Harris D, Wang JJ, Mitchell P, Prince R, Lim WH, Lewis J, Chapman J, Craig J (2016) Chronic kidney disease and the risk of cancer: an individual patient data meta-analysis of 32,057 participants from six prospective studies. BMC Cancer 16:488–498CrossRefPubMedPubMedCentral

19.

Asch WS, Bia MJ (2014) Oncologic issues and kidney transplantation: a review of frequency, mortality, and screening. Adv Chron Kidney Dis 21:106–113CrossRef

20.

Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB (2010) Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med 49:1603–1616CrossRefPubMedPubMedCentral

21.

Kato S, Chmielewski M, Honda H, Pecoits-Filho R, Matsuo S, Yuzawa Y, Tranaeus A, Stenvinkel P, Lindholm B (2008) Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol 3:1526–1533CrossRefPubMedPubMedCentral

22.

Shariat SF, Karakiewicz PI, Palapattu GS, Lotan Y, Rogers CG, Amiel GE, Vazina A, Gupta A, Bastian PJ, Sagalowsky AL, Schoenberg MP, Lerner SP (2006) Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. J Urol 176:2414–2422CrossRefPubMed

23.

Yafi FA, Aprikian AG, Chin JL, Fradet Y, Izawa J, Estey E, Fairey A, Pendon R, Cagiannos I, Lacombe L, Lattouf JB, Bell D, Drachenberg D, Kassouf W (2011) Contemporary outcomes of 2287 patients with bladder cancer who were treated with radical cystectomy: a Canadian multicentre experience. BJU Int 108:539–545CrossRefPubMed

24.

Hautmann RE, de Petriconi RC, Pfeiffer C, Volkmer BG (2012) Radical cystectomy for urothelial carcinoma of the bladder without neoadjuvant or adjuvant therapy: long-term results in 1100 patients. Eur Urol 61:1039–1047CrossRefPubMed

25.

Grossman HB, Natale RB, Tangen CM, Speights VO, Vogelzang NJ, Trump DL, deVere White RW, Sarosdy MF, Wood DP Jr, Raghavan D, Crawford ED (2003) Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 349:859–866CrossRefPubMed

26.

Griffiths G, Hall R, Sylvester R, Raghavan D, Parmar MK (2011) International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial. J Clin Oncol 29:2171–2177CrossRefPubMed

Title: Preoperative chronic kidney disease is predictive of oncological outcome of radical cystectomy for bladder cancer
Authors: Akihiko Matsumoto
Tohru Nakagawa
Atsushi Kanatani
Masaomi Ikeda
Taketo Kawai
Jimpei Miyakawa
Satoru Taguchi
Akihiro Naito
Masafumi Otsuka
Yasukazu Nakanishi
Motofumi Suzuki
Fumitaka Koga
Yasushi Nagase
Yasushi Kondo
Toshikazu Okaneya
Yoshinori Tanaka
Hideyo Miyazaki
Tetsuya Fujimura
Hiroshi Fukuhara
Haruki Kume
Yasuhiko Igawa
Yukio Homma
Publication date: 01-02-2018
Publisher: Springer Berlin Heidelberg
Published in: World Journal of Urology / Issue 2/2018
Print ISSN: 0724-4983
Electronic ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-017-2141-2

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Preoperative chronic kidney disease is predictive of oncological outcome of radical cystectomy for bladder cancer

Abstract

Purpose

Methods

Results

Conclusions

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 2/2018

Thulium–yttrium–aluminium–garnet (Tm:YAG) laser treatment of penile cancer: oncological results, functional outcomes, and quality of life

Management of biochemically recurrent prostate cancer: molecular imaging perspective

Patterns and predictors of recurrence after open radical cystectomy for bladder cancer: a comprehensive review of the literature

Renal function recovery after radical nephroureterectomy for upper tract urothelial carcinoma

PSA kinetics following primary focal cryotherapy (hemiablation) in organ-confined prostate cancer patients

Accuracy and prognostic value of variant histology and lymphovascular invasion at transurethral resection of bladder